Search - tctmd.com

Displaying 741 - 760 of 2327

Sort: Relevancy | Date

Presentation TCT 2022

Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry

Presenter: Mohamad Alkhouli

September 17, 2022

News Conference News TCT 2022

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

Yael L. Maxwell

September 17, 2022

Presentation TCT 2022

TCT 643: Successful Cardioband implantation in patient with severe tricuspid regurgitation and a long segment of right coronary artery proximity

Presenter: Angel Sanchez-Recalde

September 17, 2022

$TCT 740: Transcatheter solution for a massive tricuspid regurgitation and refractory right side heart failure in a patient with a previous cardiac transplantation.$

Presentation TCT 2022

TCT 740: Transcatheter solution for a massive tricuspid regurgitation and refractory right side heart failure in a patient with a previous cardiac transplantation.

Presenter: Rogério Sarmento-Leite

September 17, 2022

Presentation TCT 2022

CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings

Presenter: Konstantinos Koulogiannis, Scott Lim

September 17, 2022

News Conference News TCT 2022

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

Michael O'Riordan

September 17, 2022

Presentation TCT 2022

First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation

Presenter: David Adams

September 17, 2022

News Conference News TCT 2022

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

Todd Neale

September 16, 2022

News Daily News

FDA Approves Pascal TEER Device for Degenerative MR

Shelley Wood

September 15, 2022

News Daily News

New-Onset AF Not Uncommon After Mitral TEER

Todd Neale

September 13, 2022

News Daily News

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

L.A. McKeown

September 09, 2022

News Conference News ESC 2022

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Shelley Wood

September 01, 2022

News Daily News

Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis

L.A. McKeown

August 09, 2022

News Daily News

CMR Could Refine Early Management Decisions in Aortic Regurgitation

L.A. McKeown

July 27, 2022

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Daily News

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Michael O'Riordan

June 21, 2022

News Features TVT 2022

Minorities, Poorer Patients Missing Out on Structural Heart Care

Michael O'Riordan

June 15, 2022

News Conference News TVT 2022

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Michael O'Riordan

June 13, 2022

Presentation TVT 2022

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

Presenter: Philipp Lurz

June 10, 2022

Advertisement

Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry

TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR

TCT 643: Successful Cardioband implantation in patient with severe tricuspid regurgitation and a long segment of right coronary artery proximity

TCT 740: Transcatheter solution for a massive tricuspid regurgitation and refractory right side heart failure in a patient with a previous cardiac transplantation.

CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings

Pascal TEER Device as Good as MitraClip in Head-to-Head CLASP IID

First Report of Outcomes in the TRILUMINATE Pivotal Clinical Trial in Patients With Severe Tricuspid Regurgitation

HF Devices Have a Role to Play, Even With Today’s GDMT Bonanza

FDA Approves Pascal TEER Device for Degenerative MR

New-Onset AF Not Uncommon After Mitral TEER

FDA, Abbott Warn of Potential MitraClip Locking Malfunctions

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

Not All Moderate Aortic Stenosis Is the Same—Neither Is Prognosis

CMR Could Refine Early Management Decisions in Aortic Regurgitation

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Minimalist Valve-in-Valve TMVR as Safe as Conventional Approach

Minorities, Poorer Patients Missing Out on Structural Heart Care

Less Paravalvular Leak With Newer Acurate neo2 TAVI: Registry

Bringing Physiology to the Bedside: Evaluating Right Ventricular and Left Ventricular Function and Right Ventricular-Pulmonary Arterial Coupling in the Patient With Significant Tricuspid Regurgitation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content